Compound ID | 1842
Class: Aminoglycoside
| Spectrum of activity: | Gram-negative | 
| Details of activity: | Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. Active against Gram-positive and Gram-negative bacteria | 
| Description: | Streptomyces natural product. Veterinary use, rarely used in human medicine (e.g. Neisseria gonorrhoeae) | 
| Year first mentioned: | 1961 | 
| Highest developmental phase: | Approved by FDA in 1971 | 
| Development status: | Approved, off-patent | 
| Chemical structure(s): | |||||||||||
                               
  | 
                                               
                                               
                                               
                                               
                           
                           
                               
  | 
                                       
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/15541 | 
| Guide to Pharmacology: | spectinomycin | 
| Citation: | https://pubmed.ncbi.nlm.nih.gov/13867836/ |